This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Valli, V. E. Articles by Moore, P. F. Search for Related Content PubMed PubMed Citation Articles by Valli, V. E. Articles by Moore, P. F.

Canine Indolent Nodular Lymphoma

Department of Pathobiology (VEV) and Clinical Medicine (LPdL), College of Veterinary Medicine, University of Illinois at Urbana-Champaign, IL, Department of Pathobiology, Microbiology and Immunology, University of California–Davis, CA (WV, PSG, PFM)

Sixty-six cases of indolent canine lymphoid proliferation were reviewed. Age ranged from 1.5 to 16 years (median 9.0 years). Dogs of 26 breeds, plus 13 of mixed breeding or unknown lineage, were represented. B-Cell lymphomas (CD79a⁺) predominated. Marginal zone lymphoma (MZL), the largest group, involved lymph node (33 cases) and spleen (13 cases), with both tissues involved in five of these cases. Follicular lymphoma (FL) involved lymph nodes (five cases), and mantle cell lymphoma (MCL) occurred as solitary splenic masses (three cases). Nodal CD3⁺ T-zone lymphomas (TZL) (10 cases), were included since they resembled late-stage MZL at the architectural level. Two cases of marginal zone hyperplasia (MZH) were included to aid in differentiation of early MZL. Clonality status was determined in 54 cases by analysis of immunoglobulin heavy chain (IGH) and T-cell antigen receptor gamma (TCRG) gene rearrangement. Clonal rearrangement of IGH was detected in 28 of 35 MZL cases (80%), four of four FL cases (100%) and three of three MCL cases (100%). Concurrent cross lineage rearrangement of TCRG was detected in six MZL and two FL cases. Clonal rearrangement of TCRG was documented in five of eight TZL cases (63%). Limited survival data obtained for 18 dogs indicated that the B-cell lymphomas (MZL, MCL, and FL) and the T-cell lymphoma (TZL) were associated with indolent behavior and long survival. Although to the authors' knowledge, the true incidence of canine indolent lymphomas is unknown, the tumors are not rare and may have been underrecognized. Recognition of their architectural features, routine application of immunophenotyping, and molecular clonality assessment should alleviate this.

Key words: Dogs; lymphoma; mantle cell; marginal zone; marrow; node; spleen.

Request reprints from V. E. Valli, Department of Pathobiology, College of Veterinary Medicine, University of Illinois, Room 284 SAC, 1008 W Hazelwood Dr., Urbana, IL, 61802 (USA). E-mail: vevalli{at}uiuc.edu

This article has been cited by other articles:

				J. A. Ramos-Vara, M. A. Miller, and V. E. O. Valli Immunohistochemical Detection of Multiple Myeloma 1/Interferon Regulatory Factor 4 (MUM1/IRF-4) in Canine Plasmacytoma: Comparison with CD79a and CD20 Vet. Pathol., November 1, 2007; 44(6): 875 - 884. [Abstract] [Full Text] [PDF]

				E. Cadieu and E. A. Ostrander Canine Genetics Offers New Mechanisms for the Study of Human Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2181 - 2183. [Full Text] [PDF]

				S. P. Fosmire, R. Thomas, C. M. Jubala, J. W. Wojcieszyn, V. E. O. Valli, D. M. Getzy, T. L. Smith, L. A. Gardner, M. G. Ritt, J. S. Bell, et al. Inactivation of the p16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin's T-Cell Lymphoma Vet. Pathol., July 1, 2007; 44(4): 467 - 478. [Abstract] [Full Text] [PDF]